Congress Materials

Medical Information
India
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for India Healthcare Professionals. Would you like to proceed?

I am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
I am a patient/caregiver residing in IndiaNo, go back to the patient portal
SelectI am a patient/caregiver residing in IndiaNo, go back to the patient portal
Non-India residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Polkowska-Kramek A, Theilacker C, Sato R, Hanquet G, Bruyndonckx R, Gessner BD, Begier E June 23, 2022 ISPPD 2022 Pneumococcal Disease

Mortality risk associated with Pneumococcal Community Acquired Pneumonia in adults: results of a systematic literature review and meta-analysis

View Presentation
Poster
Perdrizet J, Horn E, Hayford K, Grant L, Barry R, Huang L, McDade C, Wilson M June 23, 2022 ISPPD 2022 Pneumococcal Disease

Non-vaccine Serotype Population-level Trends for Invasive Pneumococcal Disease in Australia, Canada, Israel, England & Wales, and The United States

View Presentation
Poster
Kaur R, Grant LR, Hayford K, Arguedas A, Pichichero M June 23, 2022 ISPPD 2022 Pneumococcal Disease

Pneumococcal and Serotype Contribution: Possible Prevention by PCVs Of Recurrent Acute Otitis Media (RAOM) in Children <5 Years Old in Rochester NY, USA.

View Presentation
Poster
Waghela P, Hislop MS, Thammavongsa DA, Yolda-Carr D, Vega NJ, Couch L, Campbell M, Datta R, Martenello RA, Grant LR, Alexander-Parrish R, Arguedas A, Gessner BD, Weinberger MD, Wyllie AL June 23, 2022 ISPPD 2022 Pneumococcal Disease

Pneumococcal carriage detection in asymptomatic healthcare workers

View Presentation
Poster
Hansen K, Runow E, Torisson G, Theilacker C, Palmborg A, Pan K, Southern J, Beavon R, Gessner BD, Riesbeck K, Ahl J June 23, 2022 ISPPD 2022 Pneumococcal Disease

Pneumococcal Etiology and Serotype Distribution Among Adults Hospitalized with Radiographically Confirmed Community-acquired Pneumonia in Sweden, 2016-2018

View Presentation
Poster
Syeed S, Ghule P, Le L, Veettil S, Horn EK, Wasserman M, Perdrizet J, Thakkinstian A, Chaiyakunapruk N June 23, 2022 ISPPD 2022 Pneumococcal Disease

Pneumococcal Vaccination in Children: A Systematic Review and Meta-analysis of Cost-effectiveness Studies

View Presentation
Poster
McGrath L, Vietri J, Alfred T, Chilson E June 23, 2022 ISPPD 2022 Pneumococcal Disease

Pneumococcal Vaccine uptake among adults newly diagnosed diabetes mellitus in adults as an impetus for pneumococcal vaccination in adults

View Presentation
Poster
Chilson E, McGrath L, Miles A, Alfred T, Meche A, Yan Q, Grant L June 23, 2022 ISPPD 2022 Pneumococcal Disease

Prevalence of Medical Conditions Associated With Increased Risk of Pneumococcal Disease by Age

View Presentation
Oral Presentation
Orsi A, Mosca S, Sticchi L, Prato R, Fortunato F, Vitale F, Tramuto F, Baldo V, Baldovin T, Begier E, Montuori E, Beavon R, Gessner B, Icardi G June 23, 2022 ISPPD 2022 Pneumococcal Disease

Prevalence of Pneumococcal Serotypes Causing Community-acquired Pneumonia in the Elderly in Italy Using Urinary Antigen Detection Test: The Puma Study, 2017-2020

View Presentation
Poster
Averin A, Sato R, Atwood M, Kutrieb E, Weycker D June 23, 2022 ISPPD 2022 Pneumococcal Disease

Projected Public Health Impact of PCV20 and Updated Guidelines for Pneumococcal Vaccination Among US Adults Aged 19-64 Years with Underlying Conditions

View Presentation